(Q85174010)

English

Protective effect of l-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: Implications of modulating kynurenate as a protective strategy

scientific article published on 07 October 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Protective effect of l-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: Implications of modulating kynurenate as a protective strategy (English)

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Irma Daniela Silva Adaya

1

object named as

Daniela Silva-Adaya

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20933078

29 July 2024

author name string

Verónica Pérez-De La Cruz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Juana Villeda-Hernández

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Paul Carrillo-Mora

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Irma Gabriela González-Herrera

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Esperanza García

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Laura Colín-Barenque

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

José Pedraza-Chaverrí

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Abel Santamaría

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20933078

29 July 2024

publication date

7 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0892036210001716?httpAccept=text/xml

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

https://api.elsevier.com/content/article/PII:S0892036210001716?httpAccept=text/plain

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Neurotoxicology and Teratology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

303-312

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.

1

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Experimental models of Parkinson's disease

2

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats

3

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model

4

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

5

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Toxin-induced models of Parkinson's disease

6

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition

7

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Presynaptic kynurenate-sensitive receptors inhibit glutamate release

8

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.

9

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra

10

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine

11

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).

12

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid

13

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine

14

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils

15

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Indole-3-pyruvic and -propionic acids, kynurenic acid, and related metabolites as luminophores and free-radical scavengers

17

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

18

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Spontaneous alternation behaviour in rats: kynurenic acid attenuated deficits induced by MK-801.

19

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Neuronal cell death in Huntington's disease: a potential role for dopamine

20

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

NMDA receptor pathways as drug targets

21

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

22

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Parkinson's disease. First of two parts

23

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Parkinson's disease. First of two parts

24

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease

25

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?

26

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations

27

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid

28

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Glutamate antagonists and Parkinson's disease: a review of clinical data

29

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.

30

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease

31

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease.

32

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Kynurenine pathway and disease: an overview

34

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity

35

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine

36

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease

37

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

38

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate

39

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Dapsone prevents morphological lesions and lipid peroxidation induced by quinolinic acid in rat corpus striatum

40

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.

41

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats

42

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus

43

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

44

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

The kynurenine pathway of tryptophan degradation as a drug target

45

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Parkinson disease: etiology, pathogenesis and future of gene therapy

46

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

47

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Kynurenic acid antagonists and kynurenine pathway inhibitors

48

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Early toxic effect of 6-hydroxydopamine on extracellular concentrations of neurotransmitters in the rat striatum: an in vivo microdialysis study.

49

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain

50

1 reference

10.1016/J.NTT.2010.10.002

https://api.crossref.org/works/10.1016/J.NTT.2010.10.002

29 July 2024

Identifiers

10.1016/J.NTT.2010.10.002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933078%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85174010&oldid=2215745678"